In the meantime, recent observations showed inconsistent results of IL-2 administration; it enhanced spontaneous development of insulin-dependent diabetes in BB rats [25], turned on anergic self-reactive T cells and lead to autoimmune diseases [26]; and pharmacological dose of IL-2 treated renal cancer [24]. Here, IL2 is linked to renal carcinoma.